FDA Inspection 1278905 — Li Peng, Ph.D.
The FDA completed an inspection of Li Peng, Ph.D. on July 31, 2025 in Shijiazhuang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shijiazhuang (China)
Additional Details
Clinical BA/BE